IPO Databook: Dyadic International (DYAI US) - Sep 2026

• Dyadic International, Inc. is a global biotechnology company based in Jupiter, Florida, developing and commercializing precision-engineered, animal-free recombinant proteins and enzymes using proprietary microbial expression platforms.
• The company's common stock has been listed on Nasdaq under the symbol “DYAI” since April 17, 2019, with 40,063,703 shares outstanding as of September 10, 2026.
• The company has a history of net losses and $6.0 million in 8.0% Senior Secured Convertible Promissory Notes due March 8, 2027.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.